Ideaya raises $302M; AbbVie to seek approval in giant cell arteritis
Ideaya closes $302.4M raise: The cash came in higher than expected after Ideaya said earlier this week it
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
